Article info

Download PDFPDF

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis
  1. Correspondence to:
    Professor R K S Phillips, St Mark's Hospital, Northwick Park, Watford Road, Harrow HA1 3UJ, UK
View Full Text

Citation

Phillips RKS, Wallace MH, Lynch PM, et al
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis

Publication history

  • Accepted June 20, 2001
  • First published June 1, 2002.
Online issue publication 
June 01, 2002

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.